FRES
Price
$1.22
Change
+$0.10 (+8.93%)
Updated
Dec 23, 10:35 AM (EDT)
NKTR
Price
$0.93
Change
-$0.01 (-1.06%)
Updated
Dec 20, 04:59 PM (EDT)
66 days until earnings call
Ad is loading...

FRES vs NKTR

Header iconFRES vs NKTR Comparison
Open Charts FRES vs NKTRBanner chart's image
Fresh2 Group
Price$1.22
Change+$0.10 (+8.93%)
Volume$1.1K
CapitalizationN/A
Nektar Therapeutics
Price$0.93
Change-$0.01 (-1.06%)
Volume$8.28K
CapitalizationN/A
FRES vs NKTR Comparison Chart
Loading...
FRES
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FRES vs. NKTR commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRES is a Hold and NKTR is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (FRES: $1.12 vs. NKTR: $0.93)
Brand notoriety: FRES: Not notable vs. NKTR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FRES: 40% vs. NKTR: 90%
Market capitalization -- FRES: $2.75M vs. NKTR: $171.21M
FRES [@Biotechnology] is valued at $2.75M. NKTR’s [@Biotechnology] market capitalization is $171.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FRES’s FA Score shows that 1 FA rating(s) are green whileNKTR’s FA Score has 0 green FA rating(s).

  • FRES’s FA Score: 1 green, 4 red.
  • NKTR’s FA Score: 0 green, 5 red.
According to our system of comparison, FRES is a better buy in the long-term than NKTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FRES’s TA Score shows that 4 TA indicator(s) are bullish while NKTR’s TA Score has 4 bullish TA indicator(s).

  • FRES’s TA Score: 4 bullish, 3 bearish.
  • NKTR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, FRES is a better buy in the short-term than NKTR.

Price Growth

FRES (@Biotechnology) experienced а -13.84% price change this week, while NKTR (@Biotechnology) price change was -8.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

FRES is expected to report earnings on May 16, 2023.

NKTR is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTR($171M) has a higher market cap than FRES($2.75M). NKTR YTD gains are higher at: 64.301 vs. FRES (-87.415). FRES (-131.06M) and NKTR (-137.77M) have comparable annual earnings (EBITDA) . NKTR has higher revenues than FRES: NKTR (93.1M) vs FRES (17M).
FRESNKTRFRES / NKTR
Capitalization2.75M171M2%
EBITDA-131.06M-137.77M95%
Gain YTD-87.41564.301-136%
P/E RatioN/AN/A-
Revenue17M93.1M18%
Total CashN/A244M-
Total DebtN/A108M-
FUNDAMENTALS RATINGS
NKTR: Fundamental Ratings
NKTR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
87
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FRESNKTR
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
73%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
87%
Bullish Trend 22 days ago
75%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 20 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 6 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
View a ticker or compare two or three
Ad is loading...
FRES
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NIXX4.650.32
+7.39%
Nixxy, Inc.
TOP1.320.04
+3.13%
TOP Financial Group Limited
AU23.900.64
+2.75%
AngloGold Ashanti plc
HLLY2.760.02
+0.73%
Holley
RNW6.90-0.07
-1.00%
ReNew Energy Global plc

FRES and

Correlation & Price change

A.I.dvisor indicates that over the last year, FRES has been closely correlated with HOOK. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if FRES jumps, then HOOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FRES
1D Price
Change %
FRES100%
-2.60%
HOOK - FRES
75%
Closely correlated
-5.61%
KZIA - FRES
57%
Loosely correlated
-0.33%
NKTR - FRES
34%
Loosely correlated
-1.35%
QURE - FRES
32%
Poorly correlated
+9.76%
KPRX - FRES
31%
Poorly correlated
+0.96%
More

NKTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with NTLA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
-1.35%
NTLA - NKTR
43%
Loosely correlated
+0.83%
DNLI - NKTR
43%
Loosely correlated
-0.19%
SLS - NKTR
42%
Loosely correlated
-1.11%
MDGL - NKTR
38%
Loosely correlated
+5.12%
IPSC - NKTR
36%
Loosely correlated
+4.76%
More